AP2006003743A0 - Compounds useful for the treatment of diseases - Google Patents

Compounds useful for the treatment of diseases

Info

Publication number
AP2006003743A0
AP2006003743A0 AP2006003743A AP2006003743A AP2006003743A0 AP 2006003743 A0 AP2006003743 A0 AP 2006003743A0 AP 2006003743 A AP2006003743 A AP 2006003743A AP 2006003743 A AP2006003743 A AP 2006003743A AP 2006003743 A0 AP2006003743 A0 AP 2006003743A0
Authority
AP
ARIPO
Prior art keywords
diseases
treatment
compounds useful
compounds
useful
Prior art date
Application number
AP2006003743A
Inventor
Alan Daniel Brown
Mark Edward Bunnage
Paul Alan Glossop
Kim James
Charlotte Alice Louise Lane
Russell Andrew Lewthwatte
Graham Lunn
David Anthony Price
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04290725A external-priority patent/EP1577291A1/en
Priority claimed from GB0425064A external-priority patent/GB0425064D0/en
Application filed by Pfizer filed Critical Pfizer
Priority claimed from PCT/IB2005/000640 external-priority patent/WO2005090287A2/en
Publication of AP2006003743A0 publication Critical patent/AP2006003743A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
AP2006003743A 2004-03-17 2005-03-10 Compounds useful for the treatment of diseases AP2006003743A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04290725A EP1577291A1 (en) 2004-03-17 2004-03-17 Phenylethanolamine derivatives as beta-2 agonists
US59179004P 2004-07-27 2004-07-27
GB0425064A GB0425064D0 (en) 2004-11-12 2004-11-12 Compounds useful for the treatment of diseases
PCT/IB2005/000640 WO2005090287A2 (en) 2004-03-17 2005-03-10 Phenylethanolamine derivatives as beta-2 agonists

Publications (1)

Publication Number Publication Date
AP2006003743A0 true AP2006003743A0 (en) 2006-10-31

Family

ID=34961252

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2006003743A AP2006003743A0 (en) 2004-03-17 2005-03-10 Compounds useful for the treatment of diseases

Country Status (13)

Country Link
KR (1) KR20070026420A (en)
AP (1) AP2006003743A0 (en)
AR (1) AR048267A1 (en)
EC (1) ECSP066854A (en)
IL (1) IL177754A0 (en)
MA (1) MA28475B1 (en)
NL (1) NL1028559C2 (en)
NO (1) NO20063875L (en)
PA (1) PA8626401A1 (en)
PE (1) PE20060123A1 (en)
SV (1) SV2005002052A (en)
TW (1) TWI281396B (en)
UY (1) UY28810A1 (en)

Also Published As

Publication number Publication date
TWI281396B (en) 2007-05-21
MA28475B1 (en) 2007-03-01
NL1028559A1 (en) 2005-09-20
ECSP066854A (en) 2006-11-24
KR20070026420A (en) 2007-03-08
PE20060123A1 (en) 2006-03-08
UY28810A1 (en) 2005-10-31
TW200534846A (en) 2005-11-01
NL1028559C2 (en) 2006-04-19
NO20063875L (en) 2006-09-26
AR048267A1 (en) 2006-04-12
PA8626401A1 (en) 2006-05-16
IL177754A0 (en) 2006-12-31
SV2005002052A (en) 2005-12-13

Similar Documents

Publication Publication Date Title
IL227841A0 (en) Dihydropteridinones for the treatment of cancer diseases
EP1804794A4 (en) Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer s disease
AP2006003671A0 (en) Sulfonamide derivatives for the treatment of diseases
IL194076A0 (en) Imidazolothiazole compounds for the treatment of disease
AP2006003669A0 (en) Sulfonamide derivatives for the treatment of diseases
HK1171736A1 (en) Substituted acids for the treatment of respiratory diseases
IL195571A0 (en) Compounds for the treatment of periodontal disease
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
EP1789034A4 (en) Compounds with diphenoyl -structure for the treatment of immune diseases
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
IL177232A0 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
GB0329874D0 (en) Compounds useful for the treatment of diseases
PL1801108T3 (en) Morpholine compounds for the treatment of inflammations
EP1750698A4 (en) 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
HK1097831A1 (en) Benzopyran compounds useful for the treatment of arrhytmia
HU0500145D0 (en) Composition for the treatment of oral diseases
GB0400802D0 (en) Compounds for the treatment of disease
ZA200606780B (en) Compounds for the treatment of diseases
AP2006003743A0 (en) Compounds useful for the treatment of diseases
GB0425064D0 (en) Compounds useful for the treatment of diseases
GB0420867D0 (en) Compounds for the treatment of diseases
IL177531A0 (en) Compounds for the treatment of diseases
GB0425073D0 (en) Compounds for the treatment of diseases
IL175611A0 (en) Combinations for the treatment of proliferative diseases
GB0415352D0 (en) Compounds for the treatment of disease